WorldQuant Millennium Advisors Portfolio holdings
Top Buys
| 1 |
NVIDIA
NVDA
|
+$73.3M |
| 2 |
Apple
AAPL
|
+$69.6M |
| 3 |
ServiceNow
NOW
|
+$59.6M |
| 4 |
Chevron
CVX
|
+$56M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$44.1M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$62.8M |
| 2 |
Lowe's Companies
LOW
|
+$49.4M |
| 3 |
Humana
HUM
|
+$47.8M |
| 4 |
Edwards Lifesciences
EW
|
+$39.6M |
| 5 |
Cognizant
CTSH
|
+$35.3M |
Sector Composition
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 10.87% |
| 4 | Financials | 10.12% |
| 5 | Industrials | 9.08% |
Similar funds
WorldQuant Millennium Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, WorldQuant Millennium Advisors held 422 positions worth $5.4B, up 23% from $4.39B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
WorldQuant Millennium Advisors deployed $813M of net new capital in Q1 2023, opening 102 new positions and adding to 136 existing holdings. Its largest new stake was NVIDIA: 3,387,840 shares worth $94.1M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lam Research, an estimated $62.8M trimmed.
- WorldQuant Millennium Advisors's largest Q1 2023 buy was NVIDIA: 3,387,840 shares worth $94.1M.
- WorldQuant Millennium Advisors added most to Apple in Q1 2023, an estimated $69.6M increase.
- WorldQuant Millennium Advisors's biggest Q1 2023 reduction was Lam Research, cutting an estimated $62.8M.
- WorldQuant Millennium Advisors fully exited Lowe's Companies in Q1 2023, selling an estimated $49.4M.
- WorldQuant Millennium Advisors's ten largest holdings make up 18% of its $5.4B portfolio in Q1 2023.
- WorldQuant Millennium Advisors opened 102 new positions and closed 76 in Q1 2023.
- WorldQuant Millennium Advisors's portfolio value rose 23% quarter-over-quarter to $5.4B.
Based on WorldQuant Millennium Advisors's 13F filing for Q1 2023, filed 15 May 2023.